Journal article icon

Journal article

Leveraging crowdsourcing to facilitate the discovery of new medicines.

Abstract:
Gloomy predictions about the future of pharma have forced the industry to investigate alternative models of drug discovery. Public-private partnerships (PPPs) have the potential to revitalize the discovery and development of first-in-class therapeutics. The new PPP Arch2POCM hopes to foster biomedical innovation through precompetitive validation of pioneer therapeutic targets for human diseases. In this meeting report, we capture insights garnered from the April 2011 Arch2POCM conference.
Publication status:
Published

Actions


Access Document


Authors


Norman, TC More by this author
More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, Clinical Medicine, Structural Genomics Consortium
Edwards, AM More by this author
Yamamoto, KR More by this author
Friend, SH More by this author
Journal:
Science translational medicine
Volume:
3
Issue:
88
Pages:
88mr1
Publication date:
2011-06-05
DOI:
EISSN:
1946-6242
ISSN:
1946-6234
URN:
uuid:d877097f-a344-41a8-9ef5-9ed0faea7bb2
Source identifiers:
154579
Local pid:
pubs:154579

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP